| LncRNA |
Compound |
Cancer |
P-value |
Effect |
| ENSG00000250900.2 |
Bexarotene |
Bladder urothelial carcinoma |
0.001886305 |
Resistant |
| ENSG00000250900.2 |
Bexarotene |
Colon adenocarcinoma |
0.013957691 |
Sensitive |
| ENSG00000250900.2 |
Bexarotene |
Lung squamous cell carcinoma |
0.016982878 |
Sensitive |
